Cargando…
Dipyridamole increases VP16 growth inhibition, accumulation and retention in parental and multidrug-resistant CHO cells.
Dipyridamole (DP) has been shown to reverse multidrug resistance (MDR) via interactions with P-glycoprotein (P-gp). The effect of DP on VP16 growth inhibition was investigated in parental (CHO-K1) and MDR (CHO-Adr(r)) Chinese hamster ovary cells. CHO-Adr(r) cells were 18-fold resistant to VP16 and i...
Autores principales: | Turner, R. N., Curtin, N. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074266/ https://www.ncbi.nlm.nih.gov/pubmed/8611395 |
Ejemplares similares
-
Selective potentiation of lometrexol growth inhibition by dipyridamole through cell-specific inhibition of hypoxanthine salvage.
por: Turner, R. N., et al.
Publicado: (1997) -
Dipyridamole potentiates the in vitro activity of MTA (LY231514) by inhibition of thymidine transport
por: Smith, P G, et al.
Publicado: (2000) -
Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced α(1)-acid glycoprotein binding
por: Curtin, N J, et al.
Publicado: (1999) -
Selective growth-inhibition of multidrug-resistant CHO-cells by the monoclonal antibody 265/F4.
por: Efferth, T., et al.
Publicado: (1991) -
Modulation of vinblastine sensitivity by dipyridamole in multidrug resistant fibrosarcoma cells lacking mdr1 expression.
por: Shalinsky, D. R., et al.
Publicado: (1991)